L Rackwitz1, F Djouad2, S Janjanin3, U Nöth4, R S Tuan5. 1. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. Electronic address: l.rackwitz@waldkrankenhaus.com. 2. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. Electronic address: farida.djouad@inserm.fr. 3. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA. Electronic address: s_janjanin@yahoo.com. 4. Orthopaedic Center for Musculoskeletal Research, König-Ludwig-Haus, Julius-Maximilians University, Würzburg, Germany. Electronic address: u.noeth@waldkrankenhaus.com. 5. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA; Center for Cellular and Molecular Engineering, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. Electronic address: rst13@pitt.edu.
Abstract
OBJECTIVE: The long-term performance of cell-seeded matrix-based cartilage constructs depends on (1) the development of sufficient biomechanical properties, and (2) lateral integration with host tissues, both of which require cartilage-specific matrix deposition within the scaffold. In this study, we have examined the potential of tissue-engineered cartilage analogs developed using different cell types, i.e., mesenchymal stem cells (MSCs) vs chondrocytes and de-differentiated chondrocytes, in an established "construct in cartilage ring" model. DESIGN: Cell-laden constructs of differentiated chondrocytes, de-differentiated chondrocytes after two, five or eight population doublings, and MSCs were either implanted into a native cartilage ring immediately after fabrication (immature group) or pre-treated for 21 days in a transforming growth factor-β3 (TGF-β3) containing medium prior to implantation. After additional culture for 28 days in a serum-free, chemically defined medium, the extent of lateral integration, and biochemical and biomechanical characteristics of the implants as hybrid constructs were assessed. RESULTS: The quality of integration, the amount of accumulated cartilage-specific matrix components and associated biomechanical properties were found to be highest when using differentiated chondrocytes. De-differentiation of chondrocytes negatively impacted the properties of the implants, as even two population doublings of the chondrocytes in culture significantly lowered cartilage repair capacity. In contrast, MSCs showed chondrogenic differentiation with TGF-β3 pre-treatment and superior integrational behavior. CONCLUSIONS: Chondrocyte expansion and de-differentiation impaired the cell response, resulting in inferior cartilage repair in vitro. With TGF-β3 pre-treatment, MSCs were able to undergo sustained chondrogenic differentiation and exhibited superior matrix deposition and integration compared to de-differentiated chondrocytes. Published by Elsevier Ltd.
OBJECTIVE: The long-term performance of cell-seeded matrix-based cartilage constructs depends on (1) the development of sufficient biomechanical properties, and (2) lateral integration with host tissues, both of which require cartilage-specific matrix deposition within the scaffold. In this study, we have examined the potential of tissue-engineered cartilage analogs developed using different cell types, i.e., mesenchymal stem cells (MSCs) vs chondrocytes and de-differentiated chondrocytes, in an established "construct in cartilage ring" model. DESIGN: Cell-laden constructs of differentiated chondrocytes, de-differentiated chondrocytes after two, five or eight population doublings, and MSCs were either implanted into a native cartilage ring immediately after fabrication (immature group) or pre-treated for 21 days in a transforming growth factor-β3 (TGF-β3) containing medium prior to implantation. After additional culture for 28 days in a serum-free, chemically defined medium, the extent of lateral integration, and biochemical and biomechanical characteristics of the implants as hybrid constructs were assessed. RESULTS: The quality of integration, the amount of accumulated cartilage-specific matrix components and associated biomechanical properties were found to be highest when using differentiated chondrocytes. De-differentiation of chondrocytes negatively impacted the properties of the implants, as even two population doublings of the chondrocytes in culture significantly lowered cartilage repair capacity. In contrast, MSCs showed chondrogenic differentiation with TGF-β3 pre-treatment and superior integrational behavior. CONCLUSIONS: Chondrocyte expansion and de-differentiation impaired the cell response, resulting in inferior cartilage repair in vitro. With TGF-β3 pre-treatment, MSCs were able to undergo sustained chondrogenic differentiation and exhibited superior matrix deposition and integration compared to de-differentiated chondrocytes. Published by Elsevier Ltd.
Authors: Michelle A Scott; Benjamin Levi; Asal Askarinam; Alan Nguyen; Todd Rackohn; Kang Ting; Chia Soo; Aaron W James Journal: Stem Cells Dev Date: 2012-01-04 Impact factor: 3.272
Authors: Matthias Zscharnack; Pierre Hepp; Robert Richter; Thomas Aigner; Ronny Schulz; Jeremy Somerson; Christoph Josten; Augustinus Bader; Bastian Marquass Journal: Am J Sports Med Date: 2010-05-27 Impact factor: 6.202
Authors: Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs Journal: Am J Sports Med Date: 2008-09-18 Impact factor: 6.202
Authors: K G Auw Yang; D B F Saris; R E Geuze; Y J M Van Der Helm; M H P Van Rijen; A J Verbout; W J A Dhert; L B Creemers Journal: Tissue Eng Date: 2006-09
Authors: Haneen A Abusharkh; Olivia M Reynolds; Juana Mendenhall; Bulent A Gozen; Edwin Tingstad; Vincent Idone; Nehal I Abu-Lail; Bernard J Van Wie Journal: Exp Cell Res Date: 2021-09-24 Impact factor: 4.145
Authors: Stephan Payr; Brigitte Tichy; Clemens Atteneder; Marc Michel; Thomas Tiefenboeck; Nikolaus Lang; Sylvia Nuernberger; Stefan Hajdu; Elizabeth Rosado-Balmayor; Stefan Marlovits; Christian Albrecht Journal: PLoS One Date: 2017-07-13 Impact factor: 3.240